Inhaled anaesthetic agents: from halothane to the present day.
Despite the enormous resources spent on research and development, only two new volatile agents have been introduced into anaesthetic practice in the UK since the introduction of halothane. This article reviews their properties and looks towards changes in volatile anaesthetic availability in the near future.
England
A
A
Department of Anaesthetics, Imperial College, London.
Jones
R M
RM
D000769:Anesthesia, Inhalation / Q000379:methods / Q000592:standards / Q000639:trends*; D000777:Anesthetics / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D000077335:Desflurane; D004737:Enflurane / Q000627:therapeutic use; D004987:Ethers / Q000627:therapeutic use; D006801:Humans; D007530:Isoflurane / Q000031:analogs & derivatives / Q000627:therapeutic use; D008738:Methyl Ethers; D009609:Nitrous Oxide / Q000627:therapeutic use; D000077149:Sevoflurane
D000777:Anesthetics; D004987:Ethers; D008738:Methyl Ethers; D000077149:Sevoflurane; D004737:Enflurane; D000077335:Desflurane; D007530:Isoflurane; D009609:Nitrous Oxide